In conditions in which you may well demand entry to a medically-necessary drug for a significant or daily life-threatening situation where there is no current market approved drug accessible in copyright and for which alternate typical therapies have failed or are unsuitable, Health copyright's Exclusive Accessibility Programme (SAP) is available t